INTRODUCTION
============

Alternative splicing is a common mechanism for the generation of alternative isoforms of transcripts and proteins. This process can be regulated in tissue-specific or developmental stage-specific manners, and can be responsive to signaling cues. The regulation of alternative splicing is achieved through the interplay between sequence elements of the pre-mRNA, known as *cis*-elements, and *trans*-acting splicing factor proteins that bind to them. Multiple splicing factor proteins that act to repress or activate splicing have been identified. Many of these splicing factors can be grouped into families, and different families can have antagonistic effects on alternative splicing decisions. Two main families of splicing factors have been described with detail: the SR (serine/arginine) and the hnRNPs proteins (heterogeneous nuclear ribonucleoparticles) ([@B1],[@B2]). SR proteins are generally described as splicing enhancers but they are also known to negatively regulate splicing in particular cases ([@B3]). Comparatively, proteins of the hnRNP family are generally described as negative regulators of splicing, but opposite effects have also been reported ([@B4]). Identification of alternative splicing factors and the sequences that they interact with has led to a model of a splicing code. A goal of research in the field is to solve this code so that knowledge of the regulatory elements on a pre-mRNA and their relative location, combined with knowledge of the array of splicing factors present in the nucleus, will allow for the ability to predict the outcome of alternative splicing ([@B5; @B6; @B7]).

Detailed biochemical studies of several alternatively spliced genes have shown that splicing regulation can occur through multiple distinct pre-mRNA splicing factors interacting with multiple distinct *cis*-elements. Many of these factors are ubiquitously expressed, but in combination with tissue-specific factors, splicing specificity can be achieved. The combinatorial control of alternative splicing by various *cis*-elements on specific events has been described earlier ([@B6]). A detailed analysis of the RNA features that control alternative splicing was recently published; this work takes into account many features in pre-mRNA sequences and is able to make successful predictions for how alternatively spliced regions are regulated in different tissues ([@B8]). However, the mechanisms by which *cis*-elements interacting with protein factors regulate the actual assembly of an active spliceosome are poorly understood.

Combinatorial regulation of a specific splicing event by the binding of multiple splicing factors to *cis*-elements has been demonstrated for many genes. For example PTB and hnRNP A1/A2 were recently described as common regulators of PKM alternative splicing ([@B9],[@B10]). hnRNP H and hnRNP A1 can collaborate to regulate 5′-splice site selection ([@B11]). Detailed study of the neural-specific alternative cassette exon of the c-src gene has identified polypyrimidine tract binding protein (PTB), its neural specific homolog nPTB, hnRNP H, Fox2 and other factors as participating in this tissue-specific splicing regulation ([@B12]). In a careful study to identify alternative splicing events regulated by different members of the hnRNP family of factors, RNA interference was performed on 14 different hnRNPs. Analysis of splicing by reverse transcription--polymerase chain reaction (RT--PCR) on 56 different alternative splicing events indicated that all of the splicing factors had a regulatory role for at least one of the events. Some hnRNPs, like hnRNP K, act like global regulators having effects on many alternative splicing events (\>40%), while others, such as hnRNP M, are highly specific regulators affecting \<2% of the alternative splicing events studied ([@B13]). A recent study of the binding affinities of four genes of the hnRNP A/B family shows that they have a combinatorial network of interactions, where they might regulate similar populations of mRNAs ([@B14]). A recent report also shows that hnRNP L can act as a splicing enhancer and silencer ([@B15]). In many aspects, alternative splicing decisions are analogous to transcriptional initiation; multiple factors, both positive and negative, assemble onto a nucleic acid control region, and the combination of assembled factors leads to an integrated decision (which isoform to generate by splicing or whether to initiate transcription). In order to understand splicing regulation on a global level, it will be key to uncover the interactions of multiple splicing factors with any given pre-mRNA and to reveal how these interactions lead to splicing decisions.

Most of the studies of alternative splicing regulation that uncovered multiple interacting splicing factors were performed using *ex vivo* systems. The *Caenorhabditis elegans* model system provides an excellent platform from which to probe the combinatorial interactions of alternative splicing factors on target genes in animals. Regulated alternative splicing occurs in this species, and homologs of all the major vertebrate alternative splicing factors are present in the genome ([@B16]). The use of two-color alternative splicing reporter transgenes to study splicing regulation has indicated that multiple factors in the same or different families play a role in the regulation of alternative splicing in a tissue-specific and developmental manner in these worms ([@B17; @B18; @B19]). Genetic analysis of the regulation of the alternative splicing of the *C. elegans unc-52* gene has uncovered four different splicing factor genes, *mec-8*, *smu-1*, *smu-2* and *sym-2*, which play a role in this splicing regulation ([@B20; @B21; @B22]).

In our lab, we have developed a DNA microarray that can measure changes in alternative splicing in 352 alternative cassette exons. We have previously used this platform to measure changes in splicing during *C. elegans* development and speciation, and we have used it to uncover evidence of alternative splicing coupled to developmentally-regulated non-sense-mediated decay ([@B23; @B24; @B25]). In this report, we use the splicing-sensitive DNA microarrays to analyze the differences between mRNA isolated from wild-type worms and 13 different *C. elegans* strains carrying viable genetic defects in alternative splicing factors. Our analysis uncovers many examples of coordinated regulation of alternative splicing. Examples of splicing factors that are functionally redundant, as well as splicing factors that appear to work antagonistically, are also revealed. In addition, we identify examples in which one splicing factor functions as a suppressor of an alternative splicing event at one stage of development and as an enhancer of the same alternative splicing event at a separate stage, indicating the importance of the combinatorial effect of multiple factors on splicing.

MATERIALS AND METHODS
=====================

Strains and RNA samples
-----------------------

Splicing factors mutant strains: KH1125 \[*asd-1(yb978)*\] ([@B17]), VC176 \[*exc-7(ok370)*\], CB398 \[*mec-8(e398)*\] ([@B26]), VC463 \[*rsp-2(ok639)*\], RB1451 \[*rsp-5(ok324)*\], SP2230 \[*sym-2(mn617)*\] ([@B20]), CB5380 \[*fox-1(e2643)*\] ([@B27]), VC119 \[*ptb-1(gk113)*\], VC659 \[*hrp-1(ok963)*\], CB950 \[*unc-75(e950)*\] ([@B28]) and RW2306 \[*sup-12(st89)*\] ([@B29]) were obtained from the *Caenorhabditis* Genetics Center (CGC). Strains RB1451, VC119, VC176, VC659 and VC463 were generated by the *C. elegans* Reverse Genetics Core Facility at UBC, which is part of the International *C. elegans* Gene Knockout Consortium. Strains TM3406 \[*hrpf-1(tm3406)*\] and TM367 \[*rsp-6(tm367)*\], were generated and obtained from the National BioResource Project-*C. elegans*, Japan. The *tm3406;mn617* double mutant strain was generated by conventional genetic crosses. F2 worms were screened using PCR analysis for those that were homozygous for both mutants. Worm samples: large quantities of mixed-stage worms were grown on egg--NGM plates with HB101 until plates were confluent; at that point worms were synchronized using 1% sodium hypochlorite and 0.5 M NaOH to isolate embryos. Embryo samples were taken after axenization of adults from mixed-stage cultures. Larval and adult stages were synchronized from embryos that we let hatch overnight in M9 buffer at room temperature. The next morning synchronized L1s were washed in fresh M9 and plated onto egg--NGM plates with HB101, and collected at the fourth larval stage. Total RNA samples were extracted with Trizol reagent (Invitrogen). mRNA was purified from total RNA using the PolyA Tract mRNA isolation system (Promega).

Splicing-sensitive microarrays and data analysis
------------------------------------------------

We previously reported a DNA microarray capable of detecting changes in the isoform ratios (IR) for 352 alternative cassette exons in *C. elegans* ([@B25]). cDNA derived from 2 µg of purified messenger RNA per channel were labeled with Alexa Fluor dyes (555 and 647) using the SuperScript Indirect Labeling System (Invitrogen) for each of the strains used. Hybridizations were done in duplicate with dye swaps. Data were normalized, further processed and isoform ratios (IR) were calculated as described earlier ([@B25]). In brief, a positive IR ratio equals more inclusion of the cassette exon in the reference sample (N2) while a negative IR ratio means more inclusion in the experimental sample (splicing factor mutant).

Semiquantitative and quantitative RT--PCR
-----------------------------------------

RT--PCR was performed using SuperScriptIII One-Step RT--PCR Kit (Invitrogen). An amount of 25 ng of mRNA from a sample representing a biological replica of the sample used for the microarray analysis were used in each reaction, and the number of PCR cycles was 27--30 depending on the specific mRNA targeted. Primer sequences are available upon request. PCR products were first analyzed using ethidium bromide-stained agarose gels and later quantified using an Agilent Bioanalyzer 2100 with the Agilent DNA 1000 kit (Agilent). AS ratios and inclusion proportions were calculated from the molar concentrations of each isoform as reported by the Bioanalyzer 2100 software (Agilent). For expression analysis of *mec-8*, *sup-12*, *asd-1*, *rsp-2* and *rsp-5* quantitative RT--PCR was performed for 45 cycles using Lightcycler DNA Master SYBRgreen I (Roche Applied Science, Pensberg, Germany) in 384-well plates using Lightcycler 480 (Roche), individual PCR amplifications were carried out in triplicates and two biological replicas were used to calculate average and standard deviations. The log~2~ ratios were calculated as described earlier ([@B30]), by using *gpd-2* and *rps-1* as reference housekeeping genes to normalize between samples. The log~2~ ratios represent the changes between embryos and adults, with negative values representing a downregulation of expression in adults compared to the embryo sample.

RESULTS
=======

In order to analyze the global effects on alternative splicing for different alternative splicing factors, we employed splicing-sensitive microarrays that monitor the isoform ratios for 352 events of alternative splicing in *C. elegans* ([@B25]). Thirteen different strains carrying mutations in 12 alternative splicing factors and one double-mutant strain were used in this study ([Table 1](#T1){ref-type="table"}). These represent mutant alleles of homologs of a range of known mammalian splicing factors. These include members of the hnRNP F/H family (*sym-2*, *hrpf-1*), the SR protein family (*rsp-2*, *rsp-5*, *rsp-6*), hnRNP A1 (*hrp-1*), the Fox1/2 family (*fox-1*, *asd-1*), a muscle-specific factor (*sup-12*), a neural-specific ELAV homolog (*exc-7*), a regulator of splicing whose loss leads to mechanosensory defects (*mec-8*) and a homolog of PTB (*ptb-1*). Eight of these mutants correspond to genomic deletions that remove several exons of each splicing factor (it is assumed that many are null alleles but we have no additional data as to whether these are complete or partial loss-of-function); *mec-8(e398)* is an amber mutation; the *asd-1*, *sup-12* and *sym-2* alleles used here are missense mutations that were previously characterized as null alleles ([@B17],[@B22],[@B31]). Messenger RNA was isolated from synchronized embryos for each of the mutant strains and compared against wild-type Bristol N2 embryonic mRNA on the microarrays, with replicates used in dye-swap experiments. The number of alternative splicing events for each strain that show \>2-fold changes in isoform ratios (IR) are indicated in [Table 1](#T1){ref-type="table"} \[See 'Materials and Methods' section and ([@B23]) for details in how IR was calculated\]. Table 1.Alternative splicing ratio changes in mutant strainsMutantGenes with isoformHuman homologMutationReferencesRatio changes \>2-fold*asd-1(yb978)*3FOX1/2Missense mutation G140R([@B17])*exc-7(ok370)*0ELAV 41404-bp deletion*C. elegans* Gene Knockout consortium*fox-1(e2643)*30FOX1/21255-bp deletion([@B27])*hrp-1(ok963)*11hnRNP A1843-bp deletion*C. elegans* Gene Knockout consortium*hrpf-1(tm3406)*1hnRNP F/H426-bp deletionNational BioResource Project, *C. elegansmec-8(e398)*17RBPMS2Amber mutation Q177X([@B39])*ptb-1(gk113)*8PTB542-bp deletion*C. elegans* Gene Knockout consortium*rsp-2(ok639)*10SRSF4 (SRp75)984-bp deletion*C. elegans* Gene Knockout consortium*rsp-5(ok324)*13SRSF2 (SC35)1116-bp deletion*C. elegans* Gene Knockout consortium*rsp-6(tm367)*12SRSF3 (SRp20)395-bp deletionNational BioResource Project, *C. eleganssup-12(st89)*20RBM24Missense mutation within RRM, G77E([@B31])*sym-2(mn617)*3hnRNP F/HMissense mutation Y163N([@B40])*unc-75(e950)*0CUG-BP6900-bp deletion([@B33])*hrpf-1; sym-2*17hnRNP F/H843-bp deletion and missense mutationThis work[^2]

In total, we found that 134/352 (38%) events of alternative splicing measured by our microarray have at least a 2-fold change in isoform ratio in at least one mutant strain. The strain harboring a mutant allele of the splicing factor *fox-1* shows the greatest number of splicing events with \>2-fold changes, while a strain carrying a mutant allele of the neuro-specific *exc-7* gene had no detectable alternative splicing changes at this threshold ([Table 1](#T1){ref-type="table"}). [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkq767/DC1) shows the isoform ratios of each gene tested on the microarray for each of the mutant strains. In order to ascertain whether there are splicing factors that have similar functions in this analysis, we performed a hierarchical clustering of the results for the 12 single splicing factor mutant strains for all the 352 genes on the microarray ([Figure 1](#F1){ref-type="fig"}). One interesting result is that splicing factors belonging to different families cluster together (for example the SR protein *rsp-5* with the Fox1/2 protein *fox-1*), suggesting that they are involved in the co-regulation of particular splicing events and that both are required for proper control. It is important to note that the mutation to *hrp-1* is unique in this group in that homozygous mutants have very severe phenotypes and developmental delays (*C. elegans* Gene Knockout Consortium). As such, the strain used to grow the hrp-1 mutant contains a balancer, so that the embryos tested were a mixture of worms homozygous and heterozygous for the *hrp-1* mutation. Therefore, the 11 alternative splicing events showing changes above the threshold in the *hrp-1* mutant worms in [Table 1](#T1){ref-type="table"} represent a minimum estimate of targets for *hrp-1* alternative splicing regulation. Figure 1.Hierarchical clustering of splicing factors mutant strains. Isoform ratios for all 352 alternative splicing events included in the microarray were used to cluster the different mutant strains.

Several examples of redundancy in the regulation of splicing by members of the same family of factors have been reported earlier \[for examples in *C. elegans* see ([@B18],[@B32])\]. In our analysis in [Figure 1](#F1){ref-type="fig"} we noted that some members of the same family, such as *fox-1* and *asd-1*, clustered fairly closely, indicating that they have cooperative or partially overlapping functions on similar substrates. In another interesting case we saw that pairs of proteins from the same family, the hnRNP F/H genes *sym-2* and *hrpf-1*, were fairly distant in the clustering analysis. This could indicate that they function on a small number of distinct substrates, or that they have redundant function so that the majority of hnRNP F/H-dependent splicing events are unaffected by the loss of one family member. In order to test this, we generated an *hrpf-1;sym-2* double mutant strain and observed that it was viable without any obvious phenotypic defects, similar to either allele on its own. *hrpf-1* and *sym-2* represent two of the three hnRNP F/H splicing factors genes present in the worm genome, the third family member is *hrpf-2* for which no mutant allele is available. Our array analysis indicates that the double-mutant strain has many more changes in splicing isoform ratio at the \>2-fold level when compared to either mutant alone (17 changes \>2-fold for the double-mutant compared to three for the *sym-2* mutant and one for the *hrpf-1* mutant) ([Table 1](#T1){ref-type="table"}). This indicates that there are extensive alternative splicing substrates for which these two splicing factors have redundant function, and that a small number of the substrates are uniquely regulated by each. The use of the double-mutant strain for these two family members allows for the discovery of more hnRNP F/H-dependent alternative splicing events.

After examining the microarray data across the mutant strains, we were able to uncover examples of individual alternative splicing events that are regulated by multiple splicing factors. To aid in this analysis, we created a term called the co-regulation value; it is the sum for each gene of the positive value for all splicing isoform ratios relative to N2 from each of the mutant strains. The top 18 coordinately regulated genes that have at least one isoform ratio in one mutant change \>1.5 log~2~ are shown in [Table 2](#T2){ref-type="table"}. In order to further analyze these results, we confirmed by RT--PCR the alternative splicing in wild-type and mutant strains for events with high co-regulation values for RNA samples representing biological replicates of the ones used for the microarray experiments. [Figure 2](#F2){ref-type="fig"} shows the RT--PCRs for F42G9.6, *pqn-52*, C06A6.4, *lec-3* and *hrpf-1*. For these splicing events we performed RT--PCRs for all twelve splicing factors mutants and found a validation for the microarray predictions for many events, but found also other regulators that were not predicted by the microarray. We also found that several of these alternative splicing events which the array data suggested were regulated by multiple factors could not be validated. In these cases it was due to one of the alternative isoforms representing \<5% of the final transcript; this led to a technical limitation in measuring reproducible changes of these low abundance minor isoforms by semi-quantitative RT--PCR. Figure 2.RT--PCR validations of splicing changes for alternative splicing events with high co-regulation values; (**A**) F42G9.6, (**B**) *pqn-52*, (**C**) C06A6.4, (**D**) *lec-3* and (**E**) *hrpf-1*. An Agilent Bioanalyzer 2100 was used to quantitate the experimental results, error bars are shown representing results from at least two different RT--PCR reactions, and an electropherogram for each experiment is shown. Table 2.Genes showing highest co-regulation in multiple mutant strains tested on the microarrayGeneCoregulationvalueF42G9.610.75*hrpf-1*7.95*gcy-31*7.05K04H4.28.72*lec-3*9.42*egl-3*8.03*rnp-6*6.03*phy-2*6.11F11E6.16.31C06A6.46.37C06G8.36.53H14E04.26.07*mbk-2*5.62ZC518.16.21*rme-8*5.03*pqn-52*4.82*gsy-1*3.81*tnt-3*3.59[^3]

In the analysis of the effects of mutations of different factors on substrates, certain themes emerge. For example, *sup-12* and *hrpf-1* have antagonistic effects on exon inclusion for both F42G9.6 and *pqn-52* indicating that their activities counterbalance each other on these substrates ([Figure 2](#F2){ref-type="fig"}A and B). *rsp-2* and *rsp-5* mutants have opposite effects on exon inclusion for F42G9.6, but similar effects on exon inclusion for C06A6.4 ([Figure 2](#F2){ref-type="fig"}A and C). The *lec-3* gene contains two alternative cassette exons, and mutation of the neural-specific factor *exc-7* leads to a 2-fold increase in use of the downstream cassette exon and a 2-fold increase in the skipping of both cassette exons ([Figure 2](#F2){ref-type="fig"}D). *unc-75* is also a neural-specific RNA binding protein homologous to mammalian CELF/BRUNO alternative splicing factors ([@B21]). We analyzed an *unc-75* mutant for changes in *lec-3* splicing by RT--PCR and we found that, similar to mutations in *exc-7*, mutations in *unc-75* lead to a 2-fold increase in inclusion of the downstream cassette exon. These results indicate that neural-specific factors control *lec-3* alternative splicing in neurons, and that these changes are significant enough to be detected in total worm mRNA. The inclusion of the cassette exon of the splicing factor *hrpf-1* is itself regulated by other splicing factors ([Figure 2](#F2){ref-type="fig"}E). It is interesting to note that the lesion in the *hrpf-1* mutant strain is a 426-bp deletion in a region of the gene upstream of the alternative cassette exon, which should lead to a non-functional transcript; this deletion also leads to constitutive inclusion of the alternative cassette exon in those transcripts. We previously demonstrated that the skipping isoform of *hrpf-1* is a substrate for non-sense-mediated decay ([@B25]), so by lowering the inclusion of the cassette exons, the mutations in *asd-1*, *fox-1*, *ptb-1*, *rsp-5* and *rsp-6* lead to a decrease in the level of HRPF-1. With the exception of the effect of the deletion in *hrpf-1* on its own splicing, it is important to note that we could not identify any particular alternative splicing isoform that is entirely dependent on the activity of a single alternative splicing factor. This implies that inputs from multiple factors contribute to alternative splicing decisions, but that no individual decision that we assayed for is completely dependent on a single specific factor.

Changes in splicing factor activities during development
--------------------------------------------------------

Several of the alternative splicing factors mutants that have been studied in *C. elegans* have been reported to show phenotypes specifically in adult worms ([@B25],[@B31],[@B33],[@B34]). These splicing factors may also have a role in embryonic splicing that is without an obvious phenotype. To study their function in more detail we performed microarray experiments with adult mRNA for *sup-12(st89)* and *mec-8(e398)* mutant strains. MEC-8 is important for mechanosensory behavior in adult worms, and SUP-12 is a known muscle-specific splicing factor ([@B26],[@B31]). We found examples of genes whose embryonic alternative splicing is different between the *sup-12* mutant strain and wild-type but whose splicing is identical between these same strains in adults (i.e. F42G9.6 and *pqn-52*). [Table 3](#T3){ref-type="table"} summarizes the results from the analysis of the effects of *sup-12* and *mec-8* both in embryo and adult samples ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkq767/DC1) shows the isoform ratios of each gene tested on the microarray for each of the mutant strains). Surprisingly, there is no overlap between the top-scoring embryo and adult targets for *mec-8* and *sup-12*. We performed quantitative RT--PCR to detect the changes in expression levels of *mec-8* and *sup-12* between embryos and adults ([Figure 4](#F4){ref-type="fig"}). The changes in *mec-8* (log~2~ = −5.1) and *sup-12* (log~2~ = −6.2) expression during development detected by qRT--PCR together with previous reports ([@B20],[@B31]), let us conclude that both *mec-8* and *sup-12* change from broad expression in embryonic cells to tissue-specific expression in adult worms. This result suggests that developmental regulation of the transcription of target pre-mRNAs for these splicing factors, or changes in the relative number of cells in which the splicing factors are expressed, may lead to changes in detection of splicing targets. Alternatively, other factors that work in combinatorial coordination with these factors to regulate splicing may undergo changes in development that affect the outcome. Table 3.Developmental changes in splicing regulation in *mec-8(e398)* and *sup-12(st89)* mutant strainsEmbryosAdultsGeneExon*mec-8mec-8*Genes with high embryo regulation in *mec-8*    rnp-661.50.91    ZK1127.921.80.64    Y55F3AM.332.10.35    lin-1061.50.02    lat-131.9−0.44    dct-17111.70.00    unc-5317−2.20.32    sox-22−1.80.32    F55C12.12−1.7−0.46    nlp-182−1.60.25Genes with high embryo regulation in *sup-12*    F42G9.67−2.3−0.04    phy-210−1.6−0.03    gsy-15−1.6−0.26Genes with high adult regulation in *mec-8*    *unc-43*10−0.32.52    *ccch-1*30.32.35    *pqn-70*3−0.32.16    *ret-1*7−0.12.04    *gsy-1*50.92.02    *clp-1*4−0.11.67    Y97E10AR.230.21.56    *nhx-5*17−1.0−1.52    *unc-2*180.7−1.57    *ketn-1*160.1−1.62    *gip-1*60.1−1.76    F28E10.180.7−1.98    *hrpf-1*50.4−2.51    *unc-89*190.1−2.76[^4]

This change of targets for splicing regulation by specific factors during development prompted us to look at specific targets and ask whether there are changes in the factors that regulate their splicing during development. We measured the adult splicing regulation for F42G9.6 and C06A6.4, two genes with high co-regulation values in embryos as seen in [Table 2](#T2){ref-type="table"}. We performed RT--PCRs on mRNA samples from adult worms for these genes from wild-type N2 as well as *asd-1*, *rsp-2* and *rsp-5* mutant strains. The isoform proportions for these two genes in wild-type strains change during development ([Figure 3](#F3){ref-type="fig"}). Several splicing factors that have an important role in the splicing regulation in the embryonic stage, lose this regulation in the adult stage. For example, *rsp-5* mutants have a dramatic effect on C06A6.4 splicing in embryos but no effect on the splicing of this gene in adults ([Figure 3](#F3){ref-type="fig"}A). Unexpectedly we identified a splicing factor that changes its role on a specific substrate from an enhancer in embryos to a repressor in adults. In the *rsp-5* mutant strain there is a 2-fold decrease in F42G9.6 exon inclusion in embryos but this same strain shows a 1.7-fold increase in inclusion of this exon in adults. While there have been factors shown to act as a repressor or an enhancer of splicing on different substrates, to our knowledge this is the first example of an alternative splicing factor that acts as either a repressor or an enhancer of the same splicing event depending on the state of development. Expression levels of these splicing factors rule out that this change in splicing regulation could be due to the absence of *rsp-5* in adult tissues ([Figure 4](#F4){ref-type="fig"}). We detected by quantitative RT--PCR the levels of expression for *asd-1*, *rsp-2* and *rsp-5* and found that while *asd-1* and *rsp-2* have changes in expression between embryos and adults, log~2~ of −3.6 and −3.1 respectively, when compared to reference housekeeping genes, *rsp-5* maintains similar levels of expression (log~2~ = −0.6). This together with previous reports that shows that *rsp-5* is ubiquitously present in all nuclei of somatic cells of adult worms ([@B35]), shows that *rsp-5* is a constitutively expressed splicing factor. Figure 3.Developmental changes in splicing regulation. RT--PCRs with embryo and adult samples were performed for C06A6.4 (**A**) and F42G9.6 (**B**) using mRNA samples from splicing factor mutant strains identified as regulators of embryonic splicing. Figure 4.Developmental changes in expression levels for splicing factors. Detection by quantitative RT--PCR of expression changes during development for five splicing factors. Housekeeping genes *gpd-2* and *rps-1* levels were used to normalize RNA levels between embryos and adults, and the log~2~ ratio of the comparison for each factor is displayed.

DISCUSSION
==========

In this study, we report the splicing changes for 352 alternative cassette exons that occur in strains carrying 12 different viable mutations in alternative splicing factors. These viable mutants represent close to 10% of the 151 RNA Recognition Motif (RRM) containing genes in *C. elegans* ([@B36]). Close to 40% of the alternative cassette exons studied have splicing changes \>2-fold in the presence of at least one of the viable mutations. One should keep in mind that we are measuring splicing changes in RNA extracted from whole worms, yet several of the alternative splicing factors whose mutants we studied are expressed in only a subset of tissues. Therefore, it is possible that many more of the events that were unchanged in our study are indeed regulated by the splicing factors targeted, but that the changes in splicing are happening in just a few cells so when we extract RNAs from whole worms these changes are masked by the transcripts present in other tissues. For example, *exc-7* is only expressed in neurons, and in this study we were only able to identify one substrate, *lec-3*, whose splicing is regulated by *exc-7*. This number of *exc-7* substrates would likely increase if we were to perform the microarray analysis with mRNA isolated specifically from neurons. Therefore, the number of splicing targets for any given factor in this study represents a minimum estimate. As data is not available for many of the mutant strains as to the number of times the alleles were outcrossed back to N2 wild-type, it is formally possible that some of the changes in alternative splicing we observe in the different strains may derive from mutations in the strains that are harbored outside of the splicing factor. However, the *fox-1* mutant strain that showed the highest number of splicing changes in embryos ([Table 1](#T1){ref-type="table"}) has been outcrossed back to N2 less than five times. This is consistent with all those changes in splicing being due to the *fox-1* mutation. In addition, we did not observe differentially-sized RT--PCR products in our validations, consistent with a lack of new *cis*-mutations in those targets. There is still a possibility that a small number of changes in [Table 1](#T1){ref-type="table"} may derive from additional mutations in these strains outside of the documented splicing factor alleles, however our results indicate if these exist they would at best account for only a very small fraction of the changes we observe.

One advantage of this study is that it allowed us to identify and confirm several new examples of coordinated regulation of alternative splicing by multiple splicing factors ([Table 2](#T2){ref-type="table"}, [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Combinatorial regulation of alternative splicing has been identified in several systems using biochemical and genetic approaches ([@B14],[@B18],[@B37],[@B38]). Previous work on the combinatorial regulation of hnRNP A/B proteins on splicing patterns concluded that each splicing factor studied has specific affinities for overlapping populations of transcripts ([@B14]). The assembly of multiple factors onto the introns and exons of an alternative cassette exon must allow for control of the eventual recruitment of the splicing machinery to that cassette exon. However, very little is understood about the interactions between the primary RNA-binding alternative splicing factors and the spliceosome. Identifying multiple examples of combinatorial alternative splicing regulation will help in establishing models for the interactions that lead to splicing decisions.

An unexpected result was the finding that the loss of a particular splicing factor has different effects on the splicing of the same substrate at different stages of development ([Figure 3](#F3){ref-type="fig"}). We found evidence that some factors act to regulate splicing at one stage but not another. This might be due to the factor and the substrate pre-mRNA being expressed in the same cells at one stage of development but not at another. One unexpected result was the observation that mutation of the SR protein *rsp-5*, one of two *C. elegans* homologs of the mammalian splicing factor SC35, leads to opposite effects on splicing of the same substrate at different stages of development. It is an enhancer of F49G2.6 alternative cassette exon usage in embryos and a silencer of the splicing of the same exon in adults. This points to the possibility that *rsp-5* alternative splicing activity is modulated by additional, still unidentified regulators that are present in one developmental stage but not the other. This possibility is further supported by the constant expression levels of *rsp-5* during development as shown by the qRT--PCR experiments in [Figure 4](#F4){ref-type="fig"}. That we can detect a constitutive splicing factor with important yet different effects on the splicing regulation of a specific substrate at different stages of development argues that the developmental regulation is modulated by stage-specific splicing factors that cooperate with *rsp-5* to regulate splicing.

Functional redundancy on specific substrates by members of splicing factor families has been shown to occur both *in vitro* and *in vivo*, and in these cases it is important to target multiple family members in order to see a phenotype ([@B18],[@B32]). We observed this phenomenon by targeting two different hnRNP F/H family members in a double-mutant strain ([Table 1](#T1){ref-type="table"}). This double-mutant strain remained viable, but this may be due to additional functional redundancy with a third hnRNP F/H family member in *C. elegans*, *hrpf-2*. The double mutant strain allowed us to uncover many more affected substrates than mutation of either family member alone. The logical next step for the current work is the study at a global level of the effects on particular alternative splicing events of the targeting of several splicing factors at the same time. As long as these strains are viable, this should aid in the discovery of new networks of regulation that are not detectable when just one factor at a time is mutated. Our results argue the importance of studying the combinatorial effect of multiple factors on specific splicing events in order to provide more information for the deconvolution of the splicing code.
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[^1]: Present addresses: Sergio Barberan-Soler, Center for Genomic Regulation, Barcelona, 08003, Spain. Jeffrey Estella, Department of Pharmacology, University of Washington, Seattle, WA, 98195, USA.

[^2]: Microarray analysis of embryonic mRNA between indicated splicing factor mutant strains and N2. The number of genes on the microarray undergoing \>2-fold changes in isoform ratios in the mutant strain are indicated. Human homologs of the genes are indicated, as well as the type of mutation in the *C. elegans* genome.

[^3]: The co-regulation value is the sum of the positive values of the isoform ratios (log~2~) for each gene over all mutant strains tested.

[^4]: Splicing events with an isoform ratio ≥ 1.5 (log~2~) in at least one of the two stages (embryo or adults) for either *mec-8* or *sup-12*. Note that for the sup-12 mutant strain adult RNA we could detect no isoform ratios \>1.5 compared to N2 adults.
